| 2 Week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Yrs) With Neurogenic Detrusor Overactivity | Recruiting | 2008-10-01 |
| Topics: Neurogenic Detrusor Overactivity |
| Interventions: Drug: Darifenacin; Drug: Darifenacin; Drug: Darifenacin; Drug: Darifenacin |
| View entire trial record on ClinicalTrials.gov: NCT00712322 |
| A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma | Recruiting | 2011-01-01 |
| Topics: Renal Cell Carcinoma |
| Interventions: Drug: Tivozanib |
| View entire trial record on ClinicalTrials.gov: NCT01297244 |
| A Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease | Not yet recruiting | 2012-04-01 |
| Topics: Polycystic Kidney, Autosomal Dominant |
| Interventions: Drug: KD019 |
| View entire trial record on ClinicalTrials.gov: NCT01559363 |
| A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer | Recruiting | 2010-08-01 |
| Topics: Renal Cell Carcinoma; Pharmacokinetics of AGS-16M8F |
| Interventions: Drug: AGS-16M8F |
| View entire trial record on ClinicalTrials.gov: NCT01114230 |
| A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies | Recruiting | 2008-10-01 |
| Topics: Metastatic Castration-resistant Prostrate Cancer; Renal Cell Carcinoma; Metastatic Melanoma; Non-small Cell Lung Cancer |
| Interventions: Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106); Biological: BMS-936558 (MDX-1106) |
| View entire trial record on ClinicalTrials.gov: NCT00730639 |
